MEIP - MEI Pharma EPS misses by $0.01 beats on revenue November, 10 2021 04:35 PM MEI Pharma Inc. MEI Pharma (NASDAQ:MEIP): FQ1 GAAP EPS of -$0.13 misses by $0.01. Revenue of $13.39M (+249.6% Y/Y) beats by $2.84M. Press Release For further details see: MEI Pharma EPS misses by $0.01, beats on revenue